When Science,Politics,and Policy Collide: On the Regulation of Anabolic-Androgenic Steroids,Steroid Precursors,and “Dietary Supplements” in the United States
Restricted accessOtherFirst published online February, 2011
When Science,Politics,and Policy Collide: On the Regulation of Anabolic-Androgenic Steroids,Steroid Precursors,and “Dietary Supplements” in the United States
Twenty years after policy makers passed the Anabolic Steroid Control Act of 1990, adding steroids to the list of Schedule III Controlled Substances in the United States, illicit use of the drugs continues among both adolescents and adults in American society. Some of the men and women who use steroids seek enhanced athletic performance, whereas others simply want to appear more muscular. But what, exactly, is a “steroid”? The present article examines legislation surrounding actual anabolic-androgenic steroids, steroid precursors, and associated “dietary supplements,” exploring how the political interests of policy actors and the economic interests of industry lobbies have compromised regulatory efforts. Among the issues addressed are the arbitrary assignment of substances to (and exemption from) the Omnibus Controlled Substances Act and the retailing of “dietary supplements” that contain widely varying amounts of active ingredients and, in some cases, synthetic steroids. Conceptually, the article draws on the “garbage can” model of policy processes as well as the broader public arenas model of social problems, focusing on subjective issue constructions and symbolic appeals.
Aitken, C., Delalande, C., & Stanton, K. ( 2002). Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. Drug and Alcohol Dependence, 65, 303-308.
2.
Bahrke, M.S. ( 2000). Psychological effects of endogenous testosterone and anabolic-androgenic steroids. In C. E. Yesalis (Ed.), Anabolic steroids in sport and exercise (pp. 247-278). Champaign, IL: Human Kinetics.
3.
Bass, S., & Marden, E. ( 2005). The new dietary ingredient safety provision of DSHEA: A return to congressional intent. American Journal of Law & Medicine, 31, 285-304.
4.
Blumer, H. ( 1971). Social problems as collective behavior. Social Problems, 18, 298-306.
5.
Bone, P.F., & France, K.R. ( 2009). Qualified health claims on package labels. Journal of Public Policy & Marketing, 28, 253-258.
6.
Cohen, M., March, J., & Olsen, J. ( 1972). A garbage can model of organizational choice. Administrative Science Quarterly, 17, 1-25.
7.
Cohen, P.A. ( 2009). American roulette-Contaminated dietary supplements. New England Journal of Medicine, 361, 1523-1525.
8.
Cohen, P.J. ( 2005). Science, politics, and the regulation of dietary supplements: It’s time to repeal DSHEA. American Journal of Law & Medicine, 31, 175-214.
9.
CRN foundation announces five-year grant to national advertising division for review of supplement ads. (2009, November 27). Drug Week. Retrieved from http://www.newsrx.com/ newsletters/Drug-Week/2009-11-27/161127200913027W.html
10.
Dembner, A. ( 2004, March 26). Herbal industry fending off FDA. Boston Globe, p. A1.
11.
Denham, B.E. ( 1997). Sports Illustrated, "The War on Drugs," and the Anabolic Steroid Control Act of 1990: A study in agenda building and political timing . Journal of Sport & Social Issues, 21, 260-273.
12.
Denham, B.E. ( 2006). The Anabolic Steroid Control Act of 2004: A study in the political economy of drug policy. Journal of Health & Social Policy, 22, 51-78.
13.
Eitzen, D.S. ( 2006). Fair and foul: Beyond the myths and paradoxes of sport . Lanham, MD: Rowman and Littlefield .
14.
Friedl, K.E. ( 2000). Effects of anabolic steroids on physical health. In C. E. Yesalis (Ed.), Anabolic steroids in sports and exercise (pp. 175-223). Champaign, IL : Human Kinetics.
15.
Geiger, K., & Hamburger, T. ( 2009, December 6). Defining medicine more broadly: Senate healthcare proposals incorporate chiropractors, dietary supplements and other alternative treatments. Los Angeles Times, p. A1.
16.
George, A.J. ( 2003). Androgenic anabolic steroids. In D. R. Mottram (Ed.), Drugs in sport (pp. 138-188). London, UK: Routledge.
17.
Hatch, O.G. ( 1994). Congress versus the Food and Drug Administration: How one government health agency harms the public health. Journal of Public Policy & Marketing, 13, 151-154.
18.
Hilgartner, S., & Bosk, C.L. ( 1988). The rise and fall of social problems: A public arenas model. American Journal of Sociology, 94, 53-78.
19.
Hill, J.A. ( 2006). Creating balance: Problems with DSHEA and suggestions for reform. Journal of Food Law & Policy, 2, 361-396.
20.
Houlihan, B. ( 1997). Sport, policy and politics: A comparative analysis. London, UK: Routledge.
21.
Houlihan, B. ( 2002). Dying to win (2nd ed.). Strasbourg, France: Council of Europe.
22.
Kingdon, J.W. ( 2003). Agendas, alternatives, and public opinion (2nd ed.). New York, NY: Longman.
23.
Kornblut, A.E., & Wilson, D. ( 2005, April 17). Beyond BALCO-How one pill escaped the list of controlled steroids. New York Times, p. 1.
24.
Kraemer, W.J., Rubin, M.R., French, D.N., & McGuigan, M.R. (2002). Physiological effects of testosterone precursors. In M. S. Bahrke & C. E. Yesalis (Eds.), Performance-enhancing substances in sport and exercise (pp. 79-88). Champaign, IL: Human Kinetics.
25.
Maninger, N.O., Wolkowitz, M., Reus, V.I., Epel, E.S., & Mellon, S.H. ( 2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Frontiers in Neuroendocrinology , 30, 65-91.
26.
Mason, M.J. ( 1998). Drugs or dietary supplements: FDA’s enforcement of DSHEA. Journal of Public Policy & Marketing, 17, 296-302.
27.
Mason, M.J., & Scammon, D.L. ( 2000). Health claims and disclaimers: Extended boundaries and research opportunities in consumer interpretation. Journal of Public Policy & Marketing, 19, 144-150.
28.
Mencimer, S. ( 2001, September). Scorin’ with Orrin. Washington Monthly , pp. 27-35.
29.
O’Keefe, M., & Quinn, T.J. ( 2005, December 25). Beating the heat: Thanks to "94 law, supplements still poppin."New York Daily News, pp. 88-91.
30.
O’Keefe, M., & Vinton, N. ( 2009, April 28). Phils’ J.C. sues 4 for drug ban. Blames supplements for "Andro" result. New York Daily News, p. 62.
31.
Parasrampuria, J., Schwartz, K., & Petesch, R. ( 1998). Quality control of dehydroepiandrosterone [Letter to the Editor]. Journal of the American Medical Association, 280, 1565.
32.
Police these pills and powders. (2009, November 2). Boston Globe, p. 10. Retrieved from http://www.boston.com/bostonglobe/editorial_opinion/editorials/articles/2009/11/02/police_these_pills_and_powders/
33.
Quinn, T.J. ( 2007, June 3). Muscle drug finds a legal loophole. DHEA is banned in most leagues, but it’s still allowed in baseball. New York Daily News, p. 69.
34.
Reese, S.D., & Danielian, L.H. (1989). Intermedia influence and the drug issue: Converging on cocaine. In P. J. Shoemaker (Ed.), Communication campaigns about drugs: Government, media, and the public (pp. 29-45). Hillsdale, NJ : Erlbaum.
35.
Roberts, B. ( 2009, September 25). Feds raid Meridian, ID online fitness retailer Bodybuilding.com. Idaho Statesman. Retrieved from http://www.freerepublic.com/focus/f-news/2348166/posts
36.
Sardina, J. ( 1999). Misconceptions and misleading information prevail-Less regulation does not mean less danger to consumers: Dangerous herbal weight loss products. Journal of Law and Health, 14, 107-132.
37.
Schiller, W.J. ( 1995). Senators as political entrepreneurs: Using bill sponsorship to shape legislative agendas. American Journal of Political Science, 39, 186-203.
38.
Schlesinger, M. ( 2005). Weighting for Godot. Journal of Health Politics, Policy and Law, 30, 785-802.
39.
Schmidt, M.S. ( 2009, September 25). Agents raid nutrition firm. New York Times, p. B12.
40.
Singer, N., & Schmidt, M.S. ( 2009, September 30). Congress, concerned about steroids, reviews law on dietary supplements. New York Times, p. B3.
41.
Spitz, B., & Abramson, J. ( 2005). When health policy is the problem: A report from the field. Journal of Health Politics, Policy and Law, 30, 327-365.
42.
Stone, D.A. ( 1989). Causal stories and the formation of policy agendas. Political Science Quarterly, 104, 281-300.
43.
U.S. General Accounting Office. (2001, September). Health products for seniors: "Anti-aging" products pose potential for physical and economic harm (GAO-01-1129). Washington, DC: Author.
44.
U.S. General Accounting Office. (2002, July). Dietary supplements for weight loss: Limited federal oversight has focused more on marketing than on safety (GAO-02-985T). Washington, DC: Author.
45.
U.S. Government Accountability Office. (2005 , November). Anabolic steroids Are easily purchased without a prescription and present significant challenges to law enforcement officials (GAO-06-243R). Washington, DC: Author.
46.
U.S. Government Accountability Office. (2007 , October). Anabolic steroid abuse: Federal efforts to prevent and reduce anabolic steroid abuse among teenagers (GAO-08-15). Washington, DC: Author.
47.
Vladeck, D.C. ( 2000). Truth and consequences: The perils of half-truths and unsubstantiated health claims for dietary supplements. Journal of Public Policy & Marketing, 19, 132-138.
